Lancashire and South Cumbria
Formulary
9 Nutrition and blood
This chapter of the formulary is under continual development, please let the team know if you have any comments about the contents:
mlcsu.lscformulary@nhs.net
.
For more information about the formulary development process, please see:
https://www.lancsmmg.nhs.uk/lancashire-and-south-cumbria-icb-formulary-development/
09-02-01-01 Oral potassium
Potassium Chloride
Sando-K
®
First Choice
Effervescent tablets potassium 12mmol
Potassium Chloride
Kay-Cee-L
®
Second Choice
Liquid 1mmol/mL
Potassium Chloride
Slow-K
®
Second Choice
m/r tablets potassium 8mmol
Avoid unless effervescent tablets or liquid preparations inappropriate
Links
NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia
NICE TA599: Sodium zirconium cyclosilicate for treating hyperkalaemia
NICE TA623: Patiromer for treating hyperkalaemia
NICE TA623: Patiromer for treating hyperkalaemia
Key
Full Site